| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Hoyer LW | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-13 | |
| P577 | publication date | 1981-07-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | The factor VIII complex: structure and function | |
| P478 | volume | 58 |
| Q37394646 | A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity |
| Q28586884 | A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis |
| Q37562150 | ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets |
| Q36994972 | An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor |
| Q34521638 | Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation |
| Q37610888 | Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells |
| Q36212119 | Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization |
| Q34554462 | Biosynthesis of von Willebrand protein by human megakaryocytes |
| Q35192079 | Canine Von Willebrand's Disease: A Common Inherited Bleeding Disorder in Doberman Pinscher Dogs. |
| Q70352601 | Capillary hemangioblastoma: histogenesis of stromal cells |
| Q36285769 | Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody |
| Q70374013 | Co-distribution of von Willebrand factor and fibronectin in cultured rhesus endothelial cells |
| Q41503950 | Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies |
| Q36487665 | Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. |
| Q36209412 | Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function |
| Q34624113 | Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex |
| Q48660075 | Extracellular matrix permits the expression of von Willebrand's factor, uptake of di-I-acetylated low density lipoprotein and secretion of prostacyclin in cultures of endothelial cells from rat brain microvessels |
| Q33627235 | Factor VIII R:Ag as a prognostic parameter in intracranial haemorrhage |
| Q39478807 | Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen |
| Q42574416 | Failure of sodium pentobarbital anesthesia to alter 1-desamino-8-D-arginine vasopressin-induced elevations of plasma factor VIII/ von Willebrand factor in normal dogs |
| Q36209364 | Fibronectins: multifunctional modular glycoproteins |
| Q40922128 | Gene deletions correlate with the development of alloantibodies in von Willebrand disease |
| Q41504929 | Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies |
| Q33458591 | Haemostatic alterations in malaria correlate to parasitaemia |
| Q40485162 | Hemostatic studies in a newfoundland dog with idiopathic epistaxis. |
| Q47815060 | Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis |
| Q70473794 | Identification of human megakaryocytes derived from pure megakaryocytic colonies (CFU-M), megakaryocytic-erythroid colonies (CFU-M/E), and mixed hemopoietic colonies (CFU-GEMM) by antibodies against platelet associated antigens |
| Q43798491 | In vitro study of the cell populations in two cases of Kaposi's sarcoma |
| Q33446717 | Increased factor VIII/vWf levels in patients with reduced platelet number. |
| Q36212426 | Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers |
| Q24295998 | Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor |
| Q34602783 | Interaction of von Willebrand factor with human platelets in the plasma milieu |
| Q42821000 | Invertebrate vitellogenin is homologous to human von Willebrand factor |
| Q69775058 | Lack of effect of compound 48/80 on human umbilical vein endothelium |
| Q71598848 | Localization of factor VIII/von Willebrand factor and glial fibrillary acidic protein in the hemangioblastoma: implications for stromal cell histogenesis |
| Q37912981 | Microvascular endothelial cell heterogeneity: interactions with leukocytes and tumor cells |
| Q37912946 | Perioperative management of patients with von Willebrand's disease |
| Q41780896 | Platelet function and factor VIII in uremia |
| Q27687320 | Pulmonary arterial hypertension: a comparison between children and adults |
| Q36322639 | Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain |
| Q35582088 | Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII. |
| Q80273707 | Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain |
| Q38358525 | Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene |
| Q37184970 | Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease |
| Q42820621 | Specific antigen and organelle expression of a long-term rhesus endothelial cell line |
| Q42326958 | Stable expression of recombinant human coagulation factor XIII in protein-free suspension culture of Chinese hamster ovary cells |
| Q34559664 | Substructure of human von Willebrand factor |
| Q34023313 | The "normal" factor VIII concentration in plasma |
| Q34080239 | The effects of desmopressin on hemostatic parameters in the normal dog. |
| Q42110978 | The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease. |
| Q33931052 | The human genes for hemophilia A and hemophilia B flank the X chromosome fragile site at Xq27.3. |
| Q35832756 | The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies. |
| Q33157639 | The influence of vasovagal response on the coagulation system. |
| Q37671400 | Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis |
| Q37406523 | Von Willebrand factor and coagulation factor VIII in Moyamoya disease associated with Graves' disease: A case report |
| Q36247327 | Von Willebrand protein binds to extracellular matrices independently of collagen |
| Q72618107 | Von Willebrand's disease |
| Q37918423 | What is the role of the eosinophil? |
| Q93621188 | [Regulation of blood coagulation] |
| Q70123739 | [Significance of the endothelium of the vascular wall for maintaining hemostasis] |
Search more.